<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Exp Ther Med</journal-id><journal-id journal-id-type="iso-abbrev">Exp Ther Med</journal-id><journal-id journal-id-type="publisher-id">ETM</journal-id><journal-title-group><journal-title>Experimental and Therapeutic Medicine</journal-title></journal-title-group><issn pub-type="ppub">1792-0981</issn><issn pub-type="epub">1792-1015</issn><publisher><publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29434804</article-id><article-id pub-id-type="pmc">5776623</article-id><article-id pub-id-type="doi">10.3892/etm.2017.5659</article-id><article-id pub-id-type="publisher-id">ETM-0-0-5659</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>A clinical study on acupuncture in combination with routine rehabilitation therapy for early pain recovery of post-stroke shoulder-hand syndrome</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Jinling</given-names></name><xref ref-type="aff" rid="af1-etm-0-0-5659">1</xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Qinglian</given-names></name><xref ref-type="aff" rid="af1-etm-0-0-5659">1</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Lu</given-names></name><xref ref-type="aff" rid="af2-etm-0-0-5659">2</xref></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Ting</given-names></name><xref ref-type="aff" rid="af3-etm-0-0-5659">3</xref><xref rid="c1-etm-0-0-5659" ref-type="corresp"/></contrib></contrib-group><aff id="af1-etm-0-0-5659"><label>1</label>Department of Traditional Chinese Medical Rehabilitation, The Second Hospital of Dalian Medical University, Dalian, Liaoning 116000, P.R. China</aff><aff id="af2-etm-0-0-5659"><label>2</label>Department of Nursing, The Second Hospital of Dalian Medical University, Dalian, Liaoning 116031, P.R. China</aff><aff id="af3-etm-0-0-5659"><label>3</label>Cancer Clinic, The Second Hospital of Dalian Medical University, Dalian, Liaoning 116000, P.R. China</aff><author-notes><corresp id="c1-etm-0-0-5659"><italic>Correspondence to</italic>: Dr Ting Guo, Cancer Clinic, The Second Hospital of Dalian Medical University, 467 Zhongshan Road, Shahekou, Dalian, Liaoning 116000, P.R. China, E-mail: <email>guoting2170@163.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>2</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>18</day><month>12</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>18</day><month>12</month><year>2017</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>15</volume><issue>2</issue><fpage>2049</fpage><lpage>2053</lpage><history><date date-type="received"><day>16</day><month>11</month><year>2017</year></date><date date-type="accepted"><day>12</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Zheng et al.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license></permissions><abstract><p>The clinical effect of acupuncture in combination with rehabilitation therapy for post-stroke shoulder-hand syndrome (SHS) was explored. Patients (178) with post-stroke SHS who received treatment in the Dalian Second Hospital from March 2012 to March 2016 were included in this study. The patients were divided into experimental group (89 cases) and control group (89 cases). Patients in the control group received rehabilitation therapy, while those in the treatment group received acupuncture treatment in addition to rehabilitation therapy. Visual analogue scale (VAS) was applied to assess the pain degree of patients. Fugl-Meyer assessment (FMA), functional comprehensive assessment (FCA) and assessment of quality of life (QoL) were used to evaluate rehabilitation condition of the patients. Early pain relief, rehabilitation of upper extremity motor function and improvement of QoL after treatment were compared between the two groups. The scores of VAS, FMA, FCA and QoL showed obvious differences between the two groups after treatment (P&#x0003c;0.05). The scores of the experimental group were significantly better than those of the control group, and the improvement in upper extremity motor function of the patients in the experimental group was better than that of the patients in the control group. The total effective rate of the patients in the experimental group was higher than that of control group (P&#x0003c;0.05). The effect in improving the upper extremity motor function of the patients in the experimental group was better than that of control group. The scores of QoL of the patients in the experimental group were better than that of the patients in the control group (P&#x0003c;0.05). In conclusion, acupuncture in combination with rehabilitation therapy can improve early pain and rehabilitation significantly and enhance QoL for patients with post-stroke SHS, which is worthy of being widely used in clinical practice.</p></abstract><kwd-group><kwd>stroke</kwd><kwd>shoulder-hand syndrome</kwd><kwd>acupuncture</kwd><kwd>rehabilitation therapy</kwd><kwd>early pain recovery</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Shoulder-hand syndrome (SHS), also known as reflex sympathetic dystrophy (RSD) (<xref rid="b1-etm-0-0-5659" ref-type="bibr">1</xref>,<xref rid="b2-etm-0-0-5659" ref-type="bibr">2</xref>), is one of the common complications after stroke. It occurs most frequently in the first two months after stroke and its incidence is ~70% (<xref rid="b3-etm-0-0-5659" ref-type="bibr">3</xref>). The main clinical symptoms include hemiplegic shoulder pain, hand edema and pain while moving. Symptoms such as muscle atrophy, tendon contracture and joint deformity on the affected side may be observed in some patients at the late stage of the disease. Severe cases may suffer from permanent deformity of the shoulder and the fingers, which will result in severe limitation in physical activity and great reduction in quality of life (QoL) of the patients. SHS has become one of the most common complications after stroke according to the statistics (<xref rid="b4-etm-0-0-5659" ref-type="bibr">4</xref>). Although medical technology has made great progress, the pathogenesis of post-stroke SHS still remains unclear. Currently the theory of reflex sympathetic nerve damage holds the opinion that the occurrence of SHS is relevant to the autoimmune-mediated inflammatory (<xref rid="b5-etm-0-0-5659" ref-type="bibr">5</xref>) factors, but the opinion has not been proved by clinical trials. Therefore, effective means for the clinical treatment of SHS are indeficient at present, and the treatment taking the cause, pathogenesis and pathophysiology into consideration has been the important direction for rehabilitation treatment of post-stroke SHS. It was found through clinical trials that acupuncture in combination with routine rehabilitation therapy could relieve early pain, enhance QoL and improve social functions effectively for patients with post-stroke SHS.</p></sec><sec sec-type="subjects|methods"><title>Patients and methods</title><sec><title/><sec><title>General data</title><p>A total of 178 patients with post-stroke SHS that received treatment in the Second Hospital of Dalian Medical University from March, 2012 to March, 2016 were selected into the study. They were divided into experimental group and control group (89 patients in each group). Patients in the control group included 53 males and 36 females aged 46&#x02013;69 years (average, 53.35&#x000b1;3.30 years); the course of the disease was 12 days to 3 months (average, 42.03&#x000b1;7.38 days). Patients in the experimental group included 54 males and 35 females aged 47&#x02013;70 years (average, 4.25&#x000b1;3.15 years); the course of the disease was 11 days to 2.5 months (average, 41.43&#x000b1;8.01 days). The comparisons of general data of clinical characteristics between the two groups are given in <xref rid="tI-etm-0-0-5659" ref-type="table">Table I</xref>.</p></sec><sec><title>Diagnostic criteria</title><p>i) Diagnosis of stroke: International diagnostic criteria for neurological cerebrovascular diseases (2015) (<xref rid="b6-etm-0-0-5659" ref-type="bibr">6</xref>) were taken for reference. ii) Diagnosis of SHS: Criteria in rehabilitation of post-stroke SHS (<xref rid="b7-etm-0-0-5659" ref-type="bibr">7</xref>) were taken for reference.</p><p>Diagnostic criteria: patients with cerebrovascular diseases in the past; patients suffering from pain in the shoulder and the hand and swelling of the shoulder, hand and fingers with or without limited mobility on the affected side for at least 3 months; patients that were free from trauma, infection and peripheral vascular diseases in the recent past.</p><p>The study was approved by the Ethics Committee of the Second Hospital of Dalian Medical University (Dalian, China).</p></sec><sec><title>Inclusion criteria</title><p>i) Patients that were diagnosed with stroke (phase I) through computed tomography (CT), magnetic resonance imaging (MRI) and clinical manifestations. ii) Patients who were aged 45&#x02013;70 years. iii) Patients with the course of the disease ranging from 7 days to 3 months. iv) Patients that were informed, and agreed and signed the informed consent form.</p></sec><sec><title>Exclusion criteria</title><p>i) Patients with disturbance of consciousness such as somnolence and coma. ii) Patients with SHS caused by trauma and fracture. iii) Patients with transient ischemic attack. iv) Patients that were diagnosed with orthopedic disorders such as fracture of the upper extremity, scapulohumeral periarthritis and peripheral nerve injury, or mental diseases in the past. v) Patients with severe diseases of heart, kidney, liver or other organs. vi) Patients that failed to cooperate with examinations due to aphasia, loss of reading and dementia.</p></sec><sec><title>Treatment methods</title><p>Control group: Methods of rehabilitation training: i) Postural therapy: Lying on the uninjured side: The shoulder joint was stretched fully and bent at 90 degrees as much as possible under tolerable conditions; then the joints of the elbow, wrist and fingers were stretched respectively. Lying on the affected side: The shoulder joints were fully stretched forward under tolerable conditions; then joints of the elbow, dorsal extension wrist and fingers were stretched respectively. Supine position: Shoulder blades were stretched forward as much as possible under the circumstance that pain or distending pain was tolerable; then upper extremity, joints of the elbow, wrist and fingers were stretched. A bolster could be placed under the shoulder blade on the affected side to help patients recover. Sitting position: The affected extremity was placed on the shelf in front of the chest to make the shoulder blades maintain extended forward, thus preventing prolapse of the affected extremity. ii) Passive movement: Passive movement was conducted for joints of the shoulder, elbow, wrist and fingers of the affected extremity. Attention was paid to venous return when joints moved. The affected extremity was elevated appropriately to avoid congestion. iii) Active movement: Two palms of the hands touched each other with fingers interlocked. The elbow joint on the affected side was stretched actively. The uninjured upper extremity could appropriately assist the affected side to complete active movement of shoulder joint in the early stage, and the affected side was encouraged to move actively as much as possible in the late stage after the function of the patient was improved. The treatment duration was one month (45 min/time; once/day).</p><p>Experimental group: In addition to the rehabilitation training identical with that conducted for the patients in the control group, acupuncture was also carried out. The main acupoints were three Yang meridians and other meridians on the affected extremity [such as Jianyu (LIl5), Jianliao (SJ14), Jianzhen (SI9), Jianneiling (EX-UE), Quchi (LI11), Shousanli (LI10), Hegu (LI4) and Waiguan (SJ5) on the affected side]. Acupuncture was conducted once per day for one month continuously and the needle-retaining time was 30 min each time.</p></sec><sec><title>Observation indexes</title><p>The following indexes of therapeutic efficacy were evaluated and recorded for all the cases in the experimental group and those in the control group before treatment and after one-month treatment: i) Assessment of motor function: Fugl-Meyer assessment (FMA) scale of the upper extremity was adopted (<xref rid="b8-etm-0-0-5659" ref-type="bibr">8</xref>). ii) Assessment of pain: Visual analogue scale (VAS) was adopted (<xref rid="b9-etm-0-0-5659" ref-type="bibr">9</xref>). iii) Assessment of comprehensive functions: Functional comprehensive assessment (FCA) was adopted (<xref rid="b10-etm-0-0-5659" ref-type="bibr">10</xref>). iv) Assessment of QoL: QoL assessment scale was adopted.</p></sec><sec><title>Evaluation of therapeutic efficacy</title><p>Improvement value = the absolute value of (scores after treatment-scores before treatment). Improvement ratio = improvement value/scores before treatment &#x000d7;100%. Improvement ratio &#x02265;90% indicated cured; improvement ratio within 60&#x02013;89% indicated improved; improvement ratio within 20&#x02013;59% indicated effective; improvement ratio &#x0003c;20% indicated ineffective. Total effective rate = [(clinical cured cases + improved cases + effective cases)/total cases] &#x000d7;100%.</p></sec><sec><title>Statistical analysis</title><p>Data treatment was conducted by the statistical software SPSS 21.0 (IBM, Armonk, NY, USA). &#x003c7;<sup>2</sup> test was adopted for the comparison of enumeration data, and t-test was used to compare measurement data. They were expressed as mean &#x000b1; SD. P&#x0003c;0.05 indicated that the differences had statistical significance.</p></sec></sec></sec><sec sec-type="results"><title>Results</title><sec><title/><sec><title>Comparisons of efficacy of early pain and improvement of upper extremity motor function between the two groups</title><p>The total effective rate of the improvement of early pain was 92.13% in experimental group and 68.53% in control group after one-month treatment. The difference in the comparison between the two groups showed statistical significance (P&#x0003c;0.05). The experimental group (82.02%) had better effect than the control group (66.29%) in the improvement of upper extremity motor function, and the difference showed statistical significance (&#x003c7;<sup>2</sup>=5.746, P&#x0003c;0.05) (<xref rid="tII-etm-0-0-5659" ref-type="table">Table II</xref>).</p></sec><sec><title>Comparisons of each index between the two groups after treatment</title><p>The differences in the comparisons of FMA scores of motor function, VAS scores, FCA scores and QoL scores before treatment had no statistical significance (P&#x0003e;0.05). They were comparable (<xref rid="tI-etm-0-0-5659" ref-type="table">Table I</xref>). The values of each assessment index obtained after one-month treatment were compared with those obtained before treatment, which showed that both the experimental group and the control group had statistically significant differences (P&#x0003c;0.05). All the assessment indexes had some improvements after one-month treatment compared with those before treatment (<xref rid="tIII-etm-0-0-5659" ref-type="table">Table III</xref>). However, the improvement values of each index in the experimental group were better than those in the control group. The differences had statistical significance (P&#x0003c;0.05) (<xref rid="tIV-etm-0-0-5659" ref-type="table">Table IV</xref>).</p></sec></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>SHS is a common complication after stroke. If it is not treated timely, contracture and deformity of joint muscles may be caused finally, thus resulting in permanent disability, which will bring great pain to the patients. Therefore, it is of great importance to carry out early diagnosis and early inference for patients in stage I. Active and effective treatment can reduce or avoid occurrence or development of the disease to stages II and III (<xref rid="b11-etm-0-0-5659" ref-type="bibr">11</xref>). The ATLANTIS study (<xref rid="b12-etm-0-0-5659" ref-type="bibr">12</xref>) indicated that functional recovery in stroke patients was associated with the starting time of early rehabilitation therapy. Therefore, it is recommended to carry out treatment as early as possible after the disease is stabilized. There are many methods for the treatment of post-stroke SHS currently, including anti-inflammatory, analgesic and nerve-nourishing treatments with Western medicines, and acupuncture, massage, rehabilitation therapy and physical therapy with traditional Chinese medicines, but the efficacy needs to be improved. The efficacy of acupuncture therapy, a form of the treatment with traditional Chinese medicines, in the treatment of post-stroke diseases has been clinically affirmed (<xref rid="b13-etm-0-0-5659" ref-type="bibr">13</xref>&#x02013;<xref rid="b15-etm-0-0-5659" ref-type="bibr">15</xref>). However, there are few studies on the use of acupuncture therapy in the treatment of pain for patients with post-stroke SHS in China or other countries, especially the studies on early pain recovery of post-stroke SHS. Therefore, traditional acupuncture therapy in combination with rehabilitation therapy was compared with pure rehabilitation therapy in this study to explore the efficacy of acupuncture in the treatment of pain or recovery in patients with post-stroke SHS, thus seeking an effective treatment method.</p><p>The main theoretical mechanism for acupuncture to relieve pain has not yet been studied. Some scholars agree with gate-control theory put forward by Melzack <italic>et al</italic> (<xref rid="b16-etm-0-0-5659" ref-type="bibr">16</xref>), while others with Chen <italic>et al</italic> (<xref rid="b17-etm-0-0-5659" ref-type="bibr">17</xref>) who proposed another point of view (the theory of the release of endogenous analgesic substances). Human body's analgesic system can release and secrete endogenous substances with analgesic effects (such as M receptors and opioids) to improve human body's tolerance to pain, and it can also inhibit the role of pain-causing transmitters, including adrenaline, so as to achieve analgesic effect (<xref rid="b4-etm-0-0-5659" ref-type="bibr">4</xref>,<xref rid="b18-etm-0-0-5659" ref-type="bibr">18</xref>,<xref rid="b19-etm-0-0-5659" ref-type="bibr">19</xref>). Acupuncture can make the analgesic system work by stimulating nervous system of the body to achieve analgesic effect. The results of this study showed that after one-month treatment, the total effective rate of early pain was 92.13% for patients with post-stroke SHS in the experimental group and 68.53% for those in the control group receiving rehabilitation therapy alone. The efficacy of the experimental group was significantly better than that (70.1%) of the study conducted by O'Connell <italic>et al</italic> (<xref rid="b20-etm-0-0-5659" ref-type="bibr">20</xref>) and that of the study conducted by Lee <italic>et al</italic> (<xref rid="b21-etm-0-0-5659" ref-type="bibr">21</xref>) in which glucocorticoids were used to treat post-stroke SHS. The results also indirectly confirmed the efficacy of acupuncture therapy in the treatment of post-stroke SHS. The difference in the effective rate of the efficacy may be relevant to the selection of cases and physicians. In this study, the patients were selected strictly as per the diagnosis of stroke and SHS. In addition, acupuncture therapies for all the patients in the experimental group were conducted by physicians with the title of associate chief physician that have engaged in clinical acupuncture for a long time strictly as per standards to reduce differences in treatment as much as possible.</p><p>Stroke is treated to reduce the occurrence of post-stroke complications as much as possible on the basis of treating the primary disease so as to improve QoL. Results of this study indicated that 82.02% of the patients with post-stroke SHS in the experimental group showed improvement in the function of upper extremity after one-month treatment with acupuncture in combination with rehabilitation therapy, while the total effective rate of the patients in the control group receiving single rehabilitation therapy was only 66.29%. The efficacy of acupuncture in combination with rehabilitation therapy was better than that of rehabilitation therapy, and its results were basically identical with those of the study conducted by Sun <italic>et al</italic> (<xref rid="b22-etm-0-0-5659" ref-type="bibr">22</xref>). Melzack <italic>et al</italic> (<xref rid="b16-etm-0-0-5659" ref-type="bibr">16</xref>) showed that blood flow volume, edema and pain of the affected extremity were improved and QoL was also enhanced greatly after the patients with post-stroke SHS received acupuncture therapy. The results of this study revealed that patients in the two groups had some improvements in QoL, but the efficacy of the experimental group was better than that of the control group, which further affirmed the results of the study conducted by Melzack <italic>et al</italic> (<xref rid="b16-etm-0-0-5659" ref-type="bibr">16</xref>).</p><p>In conclusion, early pain and motor function of the affected extremity and QoL can be improved obviously after the patients with post-stroke SHS receive acupuncture in combination with rehabilitation therapy. Acupuncture plus rehabilitation training are worthy to be popularized clinically.</p></sec></body><back><ref-list><title>References</title><ref id="b1-etm-0-0-5659"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannan</surname><given-names>MA</given-names></name><name><surname>Sabeka</surname><given-names>MM</given-names></name><name><surname>Miah</surname><given-names>BA</given-names></name></person-group><article-title>Shoulder hand syndrome in hemispheric stroke</article-title><source>J Neurol Sci</source><volume>3</volume><fpage>167</fpage><lpage>173</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.jns.2013.07.693</pub-id></element-citation></ref><ref id="b2-etm-0-0-5659"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>I</given-names></name><name><surname>Hosokawa</surname><given-names>K</given-names></name><name><surname>Soma</surname><given-names>M</given-names></name><name><surname>Iwata</surname><given-names>M</given-names></name><name><surname>Maltais</surname><given-names>D</given-names></name></person-group><article-title>Protocol to prevent shoulder-hand syndrome after stroke</article-title><source>Arch Phys Med Rehabil</source><volume>82</volume><fpage>1619</fpage><lpage>1623</lpage><year>2001</year><pub-id pub-id-type="doi">10.1053/apmr.2001.25975</pub-id><pub-id pub-id-type="pmid">11689984</pub-id></element-citation></ref><ref id="b3-etm-0-0-5659"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jun</surname><given-names>W</given-names></name><name><surname>Xiao</surname><given-names>C</given-names></name><name><surname>Jian</surname><given-names>P</given-names></name><name><surname>Huanhuan</surname><given-names>N</given-names></name><name><surname>Cuixia</surname><given-names>Z</given-names></name><name><surname>Chuishui</surname><given-names>H</given-names></name><name><surname>Mei</surname><given-names>H</given-names></name><name><surname>Peiyu</surname><given-names>Q</given-names></name><name><surname>Ying</surname><given-names>D</given-names></name></person-group><article-title>Timeliness of the analgesic effect of superficial needling on shoulder-hand syndrome after stroke</article-title><source>World J Acupunct Moxibust</source><volume>4</volume><fpage>5</fpage><lpage>10</lpage><year>2015</year></element-citation></ref><ref id="b4-etm-0-0-5659"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Tian</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Yu</surname><given-names>P</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Wen</surname><given-names>Q</given-names></name><name><surname>Qiao</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name></person-group><article-title>Therapeutic effect of acupuncture and massage for shoulder-hand syndrome in hemiplegia patients: A clinical two-center randomized controlled trial</article-title><source>J Tradit Chin Med</source><volume>32</volume><fpage>343</fpage><lpage>349</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/S0254-6272(13)60035-7</pub-id><pub-id pub-id-type="pmid">23297553</pub-id></element-citation></ref><ref id="b5-etm-0-0-5659"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borchers</surname><given-names>AT</given-names></name><name><surname>Gershwin</surname><given-names>ME</given-names></name></person-group><article-title>Complex regional pain syndrome: A comprehensive and critical review</article-title><source>Autoimmun Rev</source><volume>13</volume><fpage>242</fpage><lpage>265</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.autrev.2013.10.006</pub-id><pub-id pub-id-type="pmid">24161450</pub-id></element-citation></ref><ref id="b6-etm-0-0-5659"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Offner</surname><given-names>H</given-names></name><name><surname>Ihara</surname><given-names>M</given-names></name><name><surname>Sch&#x000e4;bitz</surname><given-names>WR</given-names></name><name><surname>Wong</surname><given-names>PT</given-names></name></person-group><article-title>Stroke and other cerebrovascular diseases</article-title><source>Neurochem Int</source><volume>107</volume><fpage>1</fpage><lpage>3</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.neuint.2017.04.003</pub-id><pub-id pub-id-type="pmid">28392459</pub-id></element-citation></ref><ref id="b7-etm-0-0-5659"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>YY</given-names></name><name><surname>Shu</surname><given-names>JH</given-names></name><name><surname>Hsu</surname><given-names>HC</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Chang</surname><given-names>ST</given-names></name><name><surname>Kao</surname><given-names>CL</given-names></name><name><surname>Leu</surname><given-names>HB</given-names></name></person-group><article-title>The impact of rehabilitation frequencies in the first year after stroke on the risk of recurrent stroke and mortality</article-title><source>J Stroke Cerebrovasc Dis</source><volume>6</volume><fpage>1052</fpage><lpage>1057</lpage><year>2017</year></element-citation></ref><ref id="b8-etm-0-0-5659"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woytowicz</surname><given-names>EJ</given-names></name><name><surname>Rietschel</surname><given-names>JC</given-names></name><name><surname>Goodman</surname><given-names>RN</given-names></name><name><surname>Conroy</surname><given-names>SS</given-names></name><name><surname>Sorkin</surname><given-names>JD</given-names></name><name><surname>Whitall</surname><given-names>J</given-names></name><name><surname>McCombe</surname><given-names>Waller S</given-names></name></person-group><article-title>Determining levels of upper extremity movement impairment by applying a cluster analysis to the Fugl-Meyer assessment of the upper extremity in chronic stroke</article-title><source>Arch Phys Med Rehabil</source><volume>98</volume><fpage>456</fpage><lpage>462</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.apmr.2016.06.023</pub-id><pub-id pub-id-type="pmid">27519928</pub-id></element-citation></ref><ref id="b9-etm-0-0-5659"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behrend</surname><given-names>CJ</given-names></name><name><surname>Sch&#x000f6;nbach</surname><given-names>EM</given-names></name><name><surname>Vaccaro</surname><given-names>AR</given-names></name><name><surname>Coyne</surname><given-names>E</given-names></name><name><surname>Prasarn</surname><given-names>ML</given-names></name><name><surname>Rechtine</surname><given-names>GR</given-names></name></person-group><article-title>Maximum pain on visual analog scales in spinal disorders</article-title><source>Spine J</source><volume>17</volume><fpage>1061</fpage><lpage>1065</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.spinee.2016.11.017</pub-id><pub-id pub-id-type="pmid">27939747</pub-id></element-citation></ref><ref id="b10-etm-0-0-5659"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turk</surname><given-names>DC</given-names></name><name><surname>Fillingim</surname><given-names>RB</given-names></name><name><surname>Ohrbach</surname><given-names>R</given-names></name><name><surname>Patel</surname><given-names>KV</given-names></name></person-group><article-title>Assessment of psychosocial and functional impact of chronic pain</article-title><source>J Pain</source><volume>17</volume><issue>Suppl 9</issue><fpage>T21</fpage><lpage>T49</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.jpain.2016.02.006</pub-id><pub-id pub-id-type="pmid">27586830</pub-id></element-citation></ref><ref id="b11-etm-0-0-5659"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berglund</surname><given-names>A</given-names></name><name><surname>Schenck-Gustafsson</surname><given-names>K</given-names></name><name><surname>von Euler</surname><given-names>M</given-names></name></person-group><article-title>Sex differences in the presentation of stroke</article-title><source>Maturitas</source><volume>99</volume><fpage>47</fpage><lpage>50</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.maturitas.2017.02.007</pub-id><pub-id pub-id-type="pmid">28364868</pub-id></element-citation></ref><ref id="b12-etm-0-0-5659"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hacke</surname><given-names>W</given-names></name><name><surname>Donnan</surname><given-names>G</given-names></name><name><surname>Fieschi</surname><given-names>C</given-names></name><name><surname>Kaste</surname><given-names>M</given-names></name><name><surname>von Kummer</surname><given-names>R</given-names></name><name><surname>Broderick</surname><given-names>JP</given-names></name><name><surname>Brott</surname><given-names>T</given-names></name><name><surname>Frankel</surname><given-names>M</given-names></name><name><surname>Grotta</surname><given-names>JC</given-names></name><name><surname>Haley</surname><given-names>EC</given-names><suffix>Jr</suffix></name><etal/></person-group><article-title>NINDS rt-PA Study Group Investigators: Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials</article-title><source>Lancet</source><volume>363</volume><fpage>768</fpage><lpage>774</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/S0140-6736(04)15692-4</pub-id><pub-id pub-id-type="pmid">15016487</pub-id></element-citation></ref><ref id="b13-etm-0-0-5659"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yongfeng</surname><given-names>L</given-names></name><name><surname>Xiaoming</surname><given-names>M</given-names></name><name><surname>Bing</surname><given-names>Y</given-names></name><name><surname>Yanhua</surname><given-names>G</given-names></name><name><surname>Shaoyun</surname><given-names>Z</given-names></name><name><surname>Xiaodan</surname><given-names>R</given-names></name></person-group><article-title>Warm needling on the four knee acupoints combined with Chinese herb in the treatment of knee pain after stroke</article-title><source>World J Acupunct Moxibust</source><volume>25</volume><fpage>21</fpage><lpage>25</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/S1003-5257(15)30059-3</pub-id></element-citation></ref><ref id="b14-etm-0-0-5659"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>IS</given-names></name><name><surname>Ng</surname><given-names>KF</given-names></name><name><surname>Tsang</surname><given-names>HW</given-names></name></person-group><article-title>Acupuncture for dysphagia following stroke: A systematic review</article-title><source>Eur J Integr Med</source><volume>4</volume><fpage>e141</fpage><lpage>e150</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.eujim.2012.02.001</pub-id></element-citation></ref><ref id="b15-etm-0-0-5659"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yixu</surname><given-names>H</given-names></name><name><surname>Yanjun</surname><given-names>W</given-names></name><name><surname>Yebo</surname><given-names>W</given-names></name><name><surname>Limin</surname><given-names>C</given-names></name></person-group><article-title>Essence of GAO Yu-chun's experience in treatment of stroke</article-title><source>World J Acupunct Moxibust</source><volume>26</volume><fpage>42</fpage><lpage>48</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/S1003-5257(17)30047-8</pub-id></element-citation></ref><ref id="b16-etm-0-0-5659"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melzack</surname><given-names>R</given-names></name><name><surname>Stillwell</surname><given-names>DM</given-names></name><name><surname>Fox</surname><given-names>EJ</given-names></name></person-group><article-title>Trigger points andacupuncture points for pain: Correlations and implications</article-title><source>Pain</source><volume>3</volume><fpage>3</fpage><lpage>23</lpage><year>1977</year><pub-id pub-id-type="doi">10.1016/0304-3959(77)90032-X</pub-id><pub-id pub-id-type="pmid">69288</pub-id></element-citation></ref><ref id="b17-etm-0-0-5659"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>YH</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Pan</surname><given-names>HL</given-names></name><name><surname>Li</surname><given-names>M</given-names></name></person-group><article-title>Endogenous anandamide and cannabinoid receptor-2 contribute to electroacupuncture analgesia in rats</article-title><source>J Pain</source><volume>10</volume><fpage>732</fpage><lpage>739</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.jpain.2008.12.012</pub-id><pub-id pub-id-type="pmid">19409856</pub-id></element-citation></ref><ref id="b18-etm-0-0-5659"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shang</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>CC</given-names></name><name><surname>Cai</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>DS</given-names></name><name><surname>Kong</surname><given-names>LL</given-names></name></person-group><article-title>Clinical study on acupuncture combined with rehabilitation therapy for treatment of post-stroke shoulder-hand syndrome</article-title><source>Zhongguo Zhen Jiu</source><volume>28</volume><fpage>331</fpage><lpage>333</lpage><year>2008</year><comment>(In Chinese)</comment><pub-id pub-id-type="pmid">18652322</pub-id></element-citation></ref><ref id="b19-etm-0-0-5659"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Kang</surname><given-names>X</given-names></name><name><surname>Ren</surname><given-names>JL</given-names></name><name><surname>Lai</surname><given-names>XZ</given-names></name><name><surname>Tai</surname><given-names>LW</given-names></name></person-group><article-title>Effects of extended in-patient treatment training on outcome of post-stroke dysphagia</article-title><source>Eur Rev Med Pharmacol Sci: ERMPS-12713</source><comment>(Epub ahead of print)</comment></element-citation></ref><ref id="b20-etm-0-0-5659"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Connell</surname><given-names>NE</given-names></name><name><surname>Wand</surname><given-names>BM</given-names></name><name><surname>McAuley</surname><given-names>J</given-names></name><name><surname>Marston</surname><given-names>L</given-names></name><name><surname>Moseley</surname><given-names>GL</given-names></name></person-group><article-title>Interventions for treating pain and disability in adults with complex regional pain syndrome</article-title><source>Cochrane Database Syst Rev</source><volume>4</volume><fpage>CD009416</fpage><year>2013</year></element-citation></ref><ref id="b21-etm-0-0-5659"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SK</given-names></name><name><surname>Yang</surname><given-names>DS</given-names></name><name><surname>Lee</surname><given-names>JW</given-names></name><name><surname>Choy</surname><given-names>WS</given-names></name></person-group><article-title>Four treatment strategies for complex regional pain syndrome type 1</article-title><source>Orthopedics</source><volume>35</volume><fpage>e834</fpage><lpage>e842</lpage><year>2012</year><pub-id pub-id-type="doi">10.3928/01477447-20120525-21</pub-id><pub-id pub-id-type="pmid">22691654</pub-id></element-citation></ref><ref id="b22-etm-0-0-5659"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name></person-group><article-title>Effect of acupuncture plus rehabilitation training on shoulder-hand syndrome due to ischemic stroke</article-title><source>J Acupunct Tuina Sci</source><volume>10</volume><fpage>109</fpage><lpage>113</lpage><year>2012</year><pub-id pub-id-type="doi">10.1007/s11726-012-0583-z</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="tI-etm-0-0-5659" orientation="portrait" position="float"><label>Table I.</label><caption><p>Comparisons of general data between the two groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">General data</th><th align="center" valign="bottom" rowspan="1" colspan="1">Experimental group</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control group</th><th align="center" valign="bottom" rowspan="1" colspan="1">P-value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (years)</td><td align="center" valign="top" rowspan="1" colspan="1">54.25&#x000b1;3.15</td><td align="center" valign="top" rowspan="1" colspan="1">53.35&#x000b1;3.30</td><td align="center" valign="top" rowspan="1" colspan="1">0.813<sup><xref rid="tfn2-etm-0-0-5659" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sex (male/female)</td><td align="center" valign="top" rowspan="1" colspan="1">54/35</td><td align="center" valign="top" rowspan="1" colspan="1">53/36</td><td align="center" valign="top" rowspan="1" colspan="1">0.878<sup><xref rid="tfn1-etm-0-0-5659" ref-type="table-fn">a</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Course of the disease (day)</td><td align="center" valign="top" rowspan="1" colspan="1">41.43&#x000b1;8.01</td><td align="center" valign="top" rowspan="1" colspan="1">42.03&#x000b1;7.38</td><td align="center" valign="top" rowspan="1" colspan="1">0.752<sup><xref rid="tfn2-etm-0-0-5659" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Affected extremity (left/right)</td><td align="center" valign="top" rowspan="1" colspan="1">51/38</td><td align="center" valign="top" rowspan="1" colspan="1">49/40</td><td align="center" valign="top" rowspan="1" colspan="1">0.763<sup><xref rid="tfn1-etm-0-0-5659" ref-type="table-fn">a</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Scores of VAS</td><td align="center" valign="top" rowspan="1" colspan="1">6.59&#x000b1;1.98</td><td align="center" valign="top" rowspan="1" colspan="1">6.31&#x000b1;2.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.756<sup><xref rid="tfn2-etm-0-0-5659" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Scores of FMA</td><td align="center" valign="top" rowspan="1" colspan="1">25.03&#x000b1;7.37</td><td align="center" valign="top" rowspan="1" colspan="1">24.11&#x000b1;6.98</td><td align="center" valign="top" rowspan="1" colspan="1">0.841<sup><xref rid="tfn2-etm-0-0-5659" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Scores of FCA</td><td align="center" valign="top" rowspan="1" colspan="1">27.08&#x000b1;6.68</td><td align="center" valign="top" rowspan="1" colspan="1">27.89&#x000b1;7.15</td><td align="center" valign="top" rowspan="1" colspan="1">0.755<sup><xref rid="tfn2-etm-0-0-5659" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Scores of QoL</td><td align="center" valign="top" rowspan="1" colspan="1">117.28&#x000b1;27.03</td><td align="center" valign="top" rowspan="1" colspan="1">119.37&#x000b1;28.68</td><td align="center" valign="top" rowspan="1" colspan="1">0.798<sup><xref rid="tfn2-etm-0-0-5659" ref-type="table-fn">b</xref></sup></td></tr></tbody></table><table-wrap-foot><fn id="tfn1-etm-0-0-5659"><label>a</label><p>Refers to &#x003c7;<sup>2</sup> test, P&#x0003e;0.05</p></fn><fn id="tfn2-etm-0-0-5659"><label>b</label><p>refers to t-test, P&#x0003e;0.05. The general data on clinical characteristics of patients in the two groups have no statistical difference. VAS, visual analogue scale; FMA, Fugl-Meyer assessment; FCA, functional comprehensive assessment; QoL, quality of life.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tII-etm-0-0-5659" orientation="portrait" position="float"><label>Table II.</label><caption><p>Comparisons of early pain and upper extremity motor function after treatment.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Symptoms</th><th align="center" valign="bottom" rowspan="1" colspan="1">Group</th><th align="center" valign="bottom" rowspan="1" colspan="1">n</th><th align="center" valign="bottom" rowspan="1" colspan="1">Cured</th><th align="center" valign="bottom" rowspan="1" colspan="1">Improved</th><th align="center" valign="bottom" rowspan="1" colspan="1">Effective</th><th align="center" valign="bottom" rowspan="1" colspan="1">Ineffective</th><th align="center" valign="bottom" rowspan="1" colspan="1">Total effective rate</th><th align="center" valign="bottom" rowspan="1" colspan="1">P-value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Early pain</td><td align="left" valign="top" rowspan="1" colspan="1">Experimental group</td><td align="center" valign="top" rowspan="1" colspan="1">89</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">30</td><td align="center" valign="top" rowspan="1" colspan="1">27</td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">92.13%</td><td align="center" valign="top" rowspan="1" colspan="1">P=0.01<sup><xref rid="tfn3-etm-0-0-5659" ref-type="table-fn">a</xref></sup></td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Control group</td><td align="center" valign="top" rowspan="1" colspan="1">89</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">31</td><td align="center" valign="top" rowspan="1" colspan="1">28</td><td align="center" valign="top" rowspan="1" colspan="1">68.53%</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Upper extremity</td><td align="left" valign="top" rowspan="1" colspan="1">Experimental group</td><td align="center" valign="top" rowspan="1" colspan="1">89</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">35</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">82.02%</td><td align="center" valign="top" rowspan="1" colspan="1">P=0.05<sup><xref rid="tfn4-etm-0-0-5659" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">motor function</td><td align="left" valign="top" rowspan="1" colspan="1">Control group</td><td align="center" valign="top" rowspan="1" colspan="1">89</td><td align="center" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;6</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">34</td><td align="center" valign="top" rowspan="1" colspan="1">30</td><td align="center" valign="top" rowspan="1" colspan="1">66.29%</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tfn3-etm-0-0-5659"><label>a</label><p>The difference in total effective rate of the improvement of early pain between the experimental group and the control group has statistically significance (&#x003c7;<sup>2</sup>=12.68, P=0.01&#x0003c;0.05)</p></fn><fn id="tfn4-etm-0-0-5659"><label>b</label><p>The difference in the improvement of upper extremity motor function between the experimental group and the control group has statistical significance (&#x003c7;<sup>2</sup>=5.746, P&#x0003c;0.05).</p></fn></table-wrap-foot></table-wrap><table-wrap id="tIII-etm-0-0-5659" orientation="portrait" position="float"><label>Table III.</label><caption><p>Comparisons of assessment indexes between the two groups after treatment and comparisons of assessment indexes obtained before treatment with those obtained after treatment in each group.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="center" valign="bottom" colspan="2" rowspan="1">After treatment</th><th rowspan="1" colspan="1"/><th align="center" valign="bottom" colspan="2" rowspan="1">Before treatment</th><th rowspan="1" colspan="1"/></tr><tr><th rowspan="1" colspan="1"/><th align="center" valign="bottom" colspan="2" rowspan="1"><hr/></th><th rowspan="1" colspan="1"/><th align="center" valign="bottom" colspan="2" rowspan="1"><hr/></th><th rowspan="1" colspan="1"/></tr><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Assessment indexes</th><th align="center" valign="bottom" rowspan="1" colspan="1">Experimental group</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control group</th><th align="center" valign="bottom" rowspan="1" colspan="1">P-value<sup><xref rid="tfn5-etm-0-0-5659" ref-type="table-fn">a</xref></sup></th><th align="center" valign="bottom" rowspan="1" colspan="1">Experimental group</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control group</th><th align="center" valign="bottom" rowspan="1" colspan="1">P-value<sup><xref rid="tfn6-etm-0-0-5659" ref-type="table-fn">b</xref></sup></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">VAS</td><td align="center" valign="top" rowspan="1" colspan="1">2.53&#x000b1;1.78</td><td align="center" valign="top" rowspan="1" colspan="1">3.35&#x000b1;2.07</td><td align="center" valign="top" rowspan="1" colspan="1">0.01</td><td align="center" valign="top" rowspan="1" colspan="1">6.59&#x000b1;1.98</td><td align="center" valign="top" rowspan="1" colspan="1">6.31&#x000b1;2.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.01/0.02</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FMA</td><td align="center" valign="top" rowspan="1" colspan="1">39.98&#x000b1;8.72</td><td align="center" valign="top" rowspan="1" colspan="1">32.02&#x000b1;7.29</td><td align="center" valign="top" rowspan="1" colspan="1">0.008</td><td align="center" valign="top" rowspan="1" colspan="1">25.03&#x000b1;7.37</td><td align="center" valign="top" rowspan="1" colspan="1">24.11&#x000b1;6.98</td><td align="center" valign="top" rowspan="1" colspan="1">0.00/0.01</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FCA</td><td align="center" valign="top" rowspan="1" colspan="1">52.23&#x000b1;14.36</td><td align="center" valign="top" rowspan="1" colspan="1">42.01&#x000b1;19.28</td><td align="center" valign="top" rowspan="1" colspan="1">0.003</td><td align="center" valign="top" rowspan="1" colspan="1">27.08&#x000b1;6.68</td><td align="center" valign="top" rowspan="1" colspan="1">27.89&#x000b1;7.15</td><td align="center" valign="top" rowspan="1" colspan="1">0.00/0.02</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">QoL</td><td align="center" valign="top" rowspan="1" colspan="1">212.13&#x000b1;27.18</td><td align="center" valign="top" rowspan="1" colspan="1">193.67&#x000b1;27.01</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;0.05</td><td align="center" valign="top" rowspan="1" colspan="1">117.28&#x000b1;27.03</td><td align="center" valign="top" rowspan="1" colspan="1">119.37&#x000b1;28.68</td><td align="center" valign="top" rowspan="1" colspan="1">0.02/0.03</td></tr></tbody></table><table-wrap-foot><fn id="tfn5-etm-0-0-5659"><label>a</label><p>The comparisons of scores of VAS, FMA, FCA and QoL between the experimental group and the control group after one-month treatment have statistical difference (P&#x0003c;0.05).</p></fn><fn id="tfn6-etm-0-0-5659"><label>b</label><p>P-values of the comparisons of scores of VAS, FMA, FCA and QoL obtained before treatment and those obtained after treatment in each group are &#x0003c;0.05. Symptoms of the patients in the two groups are improved, and there are statistical differences in the comparisons of the values obtained after treatment with those obtained before treatment (P&#x0003c;0.05). VAS, visual analogue scale; FMA, Fugl-Meyer assessment; FCA, functional comprehensive assessment; QoL, quality of life.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tIV-etm-0-0-5659" orientation="portrait" position="float"><label>Table IV.</label><caption><p>Comparisons of improvement values of scores of VAS, FMA, FCA and QoL between the two groups of patients with SHS after treatment.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Assessment indexes</th><th align="center" valign="bottom" rowspan="1" colspan="1">Experimental group</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control group</th><th align="center" valign="bottom" rowspan="1" colspan="1">P-value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">VAS</td><td align="center" valign="top" rowspan="1" colspan="1">3.98&#x000b1;0.86</td><td align="center" valign="top" rowspan="1" colspan="1">3.53&#x000b1;0.64</td><td align="center" valign="top" rowspan="1" colspan="1">0.001<sup><xref rid="tfn7-etm-0-0-5659" ref-type="table-fn">a</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FMA</td><td align="center" valign="top" rowspan="1" colspan="1">14.45&#x000b1;3.31</td><td align="center" valign="top" rowspan="1" colspan="1">8.73&#x000b1;3.03</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;0.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FCA</td><td align="center" valign="top" rowspan="1" colspan="1">26.37&#x000b1;5.64</td><td align="center" valign="top" rowspan="1" colspan="1">17.66&#x000b1;3.45</td><td align="center" valign="top" rowspan="1" colspan="1">0.002<sup><xref rid="tfn7-etm-0-0-5659" ref-type="table-fn">a</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">QoL</td><td align="center" valign="top" rowspan="1" colspan="1">100.51&#x000b1;13.84</td><td align="center" valign="top" rowspan="1" colspan="1">76.68&#x000b1;12.46</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;0.05</td></tr></tbody></table><table-wrap-foot><fn id="tfn7-etm-0-0-5659"><label>a</label><p>P&#x0003c;0.05 indicates that the improvement conditions of patients with SHS in the experimental group are better than those in the control group after treatment. SHS, shoulder-hand syndrome; VAS, visual analogue scale; FMA, Fugl-Meyer assessment; FCA, functional comprehensive assessment; QoL, quality of life.</p></fn></table-wrap-foot></table-wrap></floats-group></article>